EXPEDIA GROUP INC (1EXPE.MI) Fundamental Analysis & Valuation

BIT:1EXPE • US30212P3038

Current stock price

199.88 EUR
-57.52 (-22.35%)
Last:

This 1EXPE.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. 1EXPE.MI Profitability Analysis

1.1 Basic Checks

  • 1EXPE had positive earnings in the past year.
  • 1EXPE had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: 1EXPE reported negative net income in multiple years.
  • Of the past 5 years 1EXPE 4 years had a positive operating cash flow.
1EXPE.MI Yearly Net Income VS EBIT VS OCF VS FCF1EXPE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

  • The Return On Assets of 1EXPE (5.53%) is better than 63.49% of its industry peers.
  • 1EXPE has a better Return On Equity (103.81%) than 98.41% of its industry peers.
  • 1EXPE has a Return On Invested Capital of 18.46%. This is amongst the best in the industry. 1EXPE outperforms 88.89% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for 1EXPE is in line with the industry average of 11.82%.
  • The last Return On Invested Capital (18.46%) for 1EXPE is above the 3 year average (10.99%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.53%
ROE 103.81%
ROIC 18.46%
ROA(3y)3.61%
ROA(5y)-0.96%
ROE(3y)48.88%
ROE(5y)5.49%
ROIC(3y)10.99%
ROIC(5y)N/A
1EXPE.MI Yearly ROA, ROE, ROIC1EXPE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

  • Looking at the Profit Margin, with a value of 9.66%, 1EXPE is in the better half of the industry, outperforming 68.25% of the companies in the same industry.
  • 1EXPE's Profit Margin has improved in the last couple of years.
  • 1EXPE's Operating Margin of 13.72% is fine compared to the rest of the industry. 1EXPE outperforms 63.49% of its industry peers.
  • 1EXPE's Operating Margin has improved in the last couple of years.
  • 1EXPE has a better Gross Margin (89.94%) than 90.48% of its industry peers.
  • In the last couple of years the Gross Margin of 1EXPE has grown nicely.
Industry RankSector Rank
OM 13.72%
PM (TTM) 9.66%
GM 89.94%
OM growth 3Y58.59%
OM growth 5Y8.82%
PM growth 3YN/A
PM growth 5Y14%
GM growth 3Y2.82%
GM growth 5Y1.74%
1EXPE.MI Yearly Profit, Operating, Gross Margins1EXPE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. 1EXPE.MI Health Analysis

2.1 Basic Checks

  • 1EXPE has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • 1EXPE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1EXPE.MI Yearly Shares Outstanding1EXPE.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
1EXPE.MI Yearly Total Debt VS Total Assets1EXPE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

  • 1EXPE has an Altman-Z score of 1.44. This is a bad value and indicates that 1EXPE is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of 1EXPE (1.44) is comparable to the rest of the industry.
  • 1EXPE has a debt to FCF ratio of 2.07. This is a good value and a sign of high solvency as 1EXPE would need 2.07 years to pay back of all of its debts.
  • The Debt to FCF ratio of 1EXPE (2.07) is better than 76.19% of its industry peers.
  • 1EXPE has a Debt/Equity ratio of 3.34. This is a high value indicating a heavy dependency on external financing.
  • 1EXPE has a Debt to Equity ratio (3.34) which is comparable to the rest of the industry.
  • Even though the debt/equity ratio score it not favorable for 1EXPE, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 3.34
Debt/FCF 2.07
Altman-Z 1.44
ROIC/WACC2.47
WACC7.47%
1EXPE.MI Yearly LT Debt VS Equity VS FCF1EXPE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B 8B

2.3 Liquidity

  • 1EXPE has a Current Ratio of 0.74. This is a bad value and indicates that 1EXPE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of 1EXPE (0.74) is comparable to the rest of the industry.
  • 1EXPE has a Quick Ratio of 0.74. This is a bad value and indicates that 1EXPE is not financially healthy enough and could expect problems in meeting its short term obligations.
  • 1EXPE's Quick ratio of 0.74 is in line compared to the rest of the industry. 1EXPE outperforms 46.03% of its industry peers.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.74
1EXPE.MI Yearly Current Assets VS Current Liabilites1EXPE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. 1EXPE.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 30.64% over the past year.
  • Measured over the past years, 1EXPE shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.98% on average per year.
EPS 1Y (TTM)30.64%
EPS 3Y32.98%
EPS 5YN/A
EPS Q2Q%58.16%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.4%

3.2 Future

  • Based on estimates for the next years, 1EXPE will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.31% on average per year.
  • The Revenue is expected to grow by 6.67% on average over the next years.
EPS Next Y15.85%
EPS Next 2Y17.69%
EPS Next 3Y14.71%
EPS Next 5Y13.31%
Revenue Next Year7.3%
Revenue Next 2Y7.21%
Revenue Next 3Y7.05%
Revenue Next 5Y6.67%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
1EXPE.MI Yearly Revenue VS Estimates1EXPE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
1EXPE.MI Yearly EPS VS Estimates1EXPE.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 20 30 40

More info and screens

Find the best growth stocksShow best growing peers

6

4. 1EXPE.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 14.83, 1EXPE is valued correctly.
  • Based on the Price/Earnings ratio, 1EXPE is valued cheaply inside the industry as 80.95% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 26.91, 1EXPE is valued a bit cheaper.
  • With a Price/Forward Earnings ratio of 12.80, 1EXPE is valued correctly.
  • 79.37% of the companies in the same industry are more expensive than 1EXPE, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of 1EXPE to the average of the S&P500 Index (23.69), we can say 1EXPE is valued slightly cheaper.
Industry RankSector Rank
PE 14.83
Fwd PE 12.8
1EXPE.MI Price Earnings VS Forward Price Earnings1EXPE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 68.25% of the companies in the same industry are more expensive than 1EXPE, based on the Enterprise Value to EBITDA ratio.
  • 79.37% of the companies in the same industry are more expensive than 1EXPE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 9.69
EV/EBITDA 10.09
1EXPE.MI Per share data1EXPE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50

4.3 Compensation for Growth

  • 1EXPE's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • 1EXPE has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as 1EXPE's earnings are expected to grow with 14.71% in the coming years.
PEG (NY)0.94
PEG (5Y)N/A
EPS Next 2Y17.69%
EPS Next 3Y14.71%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. 1EXPE.MI Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.70%, 1EXPE is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.46, 1EXPE has a dividend in line with its industry peers.
  • With a Dividend Yield of 0.70, 1EXPE pays less dividend than the S&P500 average, which is at 1.89.
Industry RankSector Rank
Dividend Yield 0.7%

5.2 History

Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

DPN/A
EPS Next 2Y17.69%
EPS Next 3Y14.71%
1EXPE.MI Yearly Income VS Free CF VS Dividend1EXPE.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

More info and screens

Find the best dividend stocksShow peers with best dividend

1EXPE.MI Fundamentals: All Metrics, Ratios and Statistics

EXPEDIA GROUP INC

BIT:1EXPE (2/5/2026, 7:00:00 PM)

199.88

-57.52 (-22.35%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-12
Earnings (Next)05-06
Inst Owners103.43%
Inst Owner ChangeN/A
Ins Owners0.52%
Ins Owner ChangeN/A
Market Cap24.49B
Revenue(TTM)N/A
Net Income(TTM)1.39B
Analysts72.73
Price Target235.09 (17.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.7%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.37%
Min EPS beat(2)1.46%
Max EPS beat(2)7.27%
EPS beat(4)4
Avg EPS beat(4)11.2%
Min EPS beat(4)1.46%
Max EPS beat(4)20.96%
EPS beat(8)7
Avg EPS beat(8)30.46%
EPS beat(12)9
Avg EPS beat(12)-11.57%
EPS beat(16)12
Avg EPS beat(16)-2.63%
Revenue beat(2)2
Avg Revenue beat(2)0.58%
Min Revenue beat(2)0.11%
Max Revenue beat(2)1.05%
Revenue beat(4)3
Avg Revenue beat(4)0%
Min Revenue beat(4)-2.83%
Max Revenue beat(4)1.66%
Revenue beat(8)4
Avg Revenue beat(8)-0.66%
Revenue beat(12)4
Avg Revenue beat(12)-1.2%
Revenue beat(16)5
Avg Revenue beat(16)-0.96%
PT rev (1m)21.99%
PT rev (3m)21.99%
EPS NQ rev (1m)-1.97%
EPS NQ rev (3m)23.49%
EPS NY rev (1m)0.03%
EPS NY rev (3m)7.98%
Revenue NQ rev (1m)0.2%
Revenue NQ rev (3m)4.63%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)1.94%
Valuation
Industry RankSector Rank
PE 14.83
Fwd PE 12.8
P/S 2.02
P/FCF 9.69
P/OCF 7.7
P/B 21.73
P/tB N/A
EV/EBITDA 10.09
EPS(TTM)13.48
EY6.74%
EPS(NY)15.62
Fwd EY7.81%
FCF(TTM)20.63
FCFY10.32%
OCF(TTM)25.97
OCFY12.99%
SpS98.87
BVpS9.2
TBVpS-43.58
PEG (NY)0.94
PEG (5Y)N/A
Graham Number52.82
Profitability
Industry RankSector Rank
ROA 5.53%
ROE 103.81%
ROCE 25.12%
ROIC 18.46%
ROICexc 86.41%
ROICexgc N/A
OM 13.72%
PM (TTM) 9.66%
GM 89.94%
FCFM 20.86%
ROA(3y)3.61%
ROA(5y)-0.96%
ROE(3y)48.88%
ROE(5y)5.49%
ROIC(3y)10.99%
ROIC(5y)N/A
ROICexc(3y)20.29%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)14.96%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y125.83%
ROICexc growth 5Y22.57%
OM growth 3Y58.59%
OM growth 5Y8.82%
PM growth 3YN/A
PM growth 5Y14%
GM growth 3Y2.82%
GM growth 5Y1.74%
F-Score9
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 3.34
Debt/FCF 2.07
Debt/EBITDA 1.57
Cap/Depr 88.28%
Cap/Sales 5.4%
Interest Coverage 8.04
Cash Conversion 132.42%
Profit Quality 215.99%
Current Ratio 0.74
Quick Ratio 0.74
Altman-Z 1.44
F-Score9
WACC7.47%
ROIC/WACC2.47
Cap/Depr(3y)92.88%
Cap/Depr(5y)87.19%
Cap/Sales(3y)5.93%
Cap/Sales(5y)8.19%
Profit Quality(3y)403.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.64%
EPS 3Y32.98%
EPS 5YN/A
EPS Q2Q%58.16%
EPS Next Y15.85%
EPS Next 2Y17.69%
EPS Next 3Y14.71%
EPS Next 5Y13.31%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.4%
Revenue Next Year7.3%
Revenue Next 2Y7.21%
Revenue Next 3Y7.05%
Revenue Next 5Y6.67%
EBIT growth 1Y28.99%
EBIT growth 3Y85.19%
EBIT growth 5Y11.61%
EBIT Next Year151.63%
EBIT Next 3Y45.49%
EBIT Next 5Y29.82%
FCF growth 1Y57.79%
FCF growth 3Y-8.85%
FCF growth 5Y7.7%
OCF growth 1Y37.44%
OCF growth 3Y-6.28%
OCF growth 5Y2.2%

EXPEDIA GROUP INC / 1EXPE.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for EXPEDIA GROUP INC?

ChartMill assigns a fundamental rating of 6 / 10 to 1EXPE.MI.


What is the valuation status of EXPEDIA GROUP INC (1EXPE.MI) stock?

ChartMill assigns a valuation rating of 7 / 10 to EXPEDIA GROUP INC (1EXPE.MI). This can be considered as Undervalued.


Can you provide the profitability details for EXPEDIA GROUP INC?

EXPEDIA GROUP INC (1EXPE.MI) has a profitability rating of 8 / 10.


What are the PE and PB ratios of EXPEDIA GROUP INC (1EXPE.MI) stock?

The Price/Earnings (PE) ratio for EXPEDIA GROUP INC (1EXPE.MI) is 14.83 and the Price/Book (PB) ratio is 21.73.


Can you provide the financial health for 1EXPE stock?

The financial health rating of EXPEDIA GROUP INC (1EXPE.MI) is 5 / 10.